(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) is pleased to announce that Claire Wulf Winiarek, an experienced health care policy leader, is joining PCMA as Vice President of Policy. PCMA also is announcing April Alexander will take on a new role as PCMA’s General Counsel and Vice President of State Regulatory Affairs.
“I am thrilled to welcome Claire to PCMA and congratulate April on her expanded role within our organization,” said PCMA President and CEO JC Scott. “They are both extraordinarily talented individuals who will be assets to our team as we continue our work to educate federal and state policymakers on the value of PBMs to lower prescription drug costs and improve pharmacy care management for patients and the healthcare system.”
Winiarek is the former Director for the Division of Managed Care Policy at the Centers for Medicare & Medicaid Services (CMS) and previously held various policy and regulatory affairs positions for Fortune 500 health care companies, including Magellan Health, Anthem, and Amerigroup. In her role as Vice President of Policy, Winiarek will direct the association’s policy development activities to support the PBM industry’s federal and state advocacy efforts.
“I am excited for the opportunity to work on behalf of an industry essential to lowering health care costs for millions of Americans,” said Winiarek. “Drug pricing, like health care costs overall, is at an important inflection point. As this outstanding association advances the essential role and value of PBMs, it is critical that we facilitate the thought leadership to drive the industry and debate forward.”
Effective beginning January 2020, April Alexander, currently a member of PCMA’s State Affairs department, will become the organization’s General Counsel and Vice President of State Regulatory Affairs.
“I am thrilled to serve PCMA in this new role and to continue supporting the industry’s fight to reduce prescription drug costs and improve health outcomes for Americans,” said Alexander.